Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial (original) (raw)

Combet, E. et al. (2024) Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial.Nature Medicine, 31(1), pp. 258-266. (doi: 10.1038/s41591-024-03384-x) (PMID:39779922) (PMCID:PMC11750722)

Abstract

Long COVID (LC) is a complex multisymptom condition with no known disease-modifying treatments. This wait-list-controlled open-label trial tested whether a remotely delivered structured weight management program could improve respective LC symptoms in people living with overweight. Adults with LC (symptoms >12 weeks) and body mass index >27 kg m−2 (>25 kg m−2 for South Asians) were randomized (n = 234, 1:1) to control (n = 116, usual care) or the remotely delivered structured weight management (n = 118, total diet replacement (850 kcal per day) for 12 weeks, followed by food reintroduction and weight loss maintenance support) via minimization and randomization (80:20) to balance dominant LC symptom, sex, age, ethnicity and postcode-based index of multiple deprivation between groups. The control group received the intervention after 6 months. Participants selected the dominant LC symptom they would most like to improve (fatigue, breathlessness, pain, anxiety/depression or other) as the prespecified respective primary outcome. Individual symptoms were assessed using validated questionnaires and a visual analog scale for those without prespecified scales. At 6 months, the primary outcome improved in the intervention group (change −1.16 (s.d. 1.42), n = 97 analyzed) compared with the control group (change −0.83 (s.d. 1.14), n = 117 analyzed) with a treatment effect of −0.34 (95% confidence interval −0.67 to −0.01), with no excess of serious adverse events. International Standard Randomised Controlled Trial Number Registry registration: ISRCTN12595520.

Item Type: Articles
Additional Information: This study (COV-LT2-0059 DB) is funded by the National Institute for Health and Care Research (NIHR) in response to the COVID-19 pandemic.
Status: Published
Refereed: Yes
Glasgow Author(s) Enlighten ID: Blane, Dr David and McConnachie, Professor Alex and Brosnahan, Dr Naomi and Cunningham, Dr Yvonne and Ormerod, Mrs Jane and Lean, Professor Michael and Richardson, Mrs Janice and Combet, Professor Emilie and Ibbotson, Dr Tracy and Haag, Ms Laura and McIntosh, Professor Emma and Haig, Dr Caroline and Sattar, Professor Naveed and O'Donnell, Professor Kate and Fraser, Miss Heather
Authors: Combet, E., Haag, L., Richardson, J., Haig, C. E., Cunningham, Y., Fraser, H. L., Brosnahan, N., Ibbotson, T., Ormerod, J., White, C., McIntosh, E., O'Donnell, C. A., Sattar, N., McConnachie, A., Lean, M., and Blane, D. N.
College/School: College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic HealthCollege of Medical Veterinary and Life Sciences > School of Health & Wellbeing > General Practice and Primary CareCollege of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology AssessmentCollege of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson CentreCollege of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name: Nature Medicine
Publisher: Nature Research
ISSN: 1078-8956
ISSN (Online): 1546-170X
Published Online: 08 January 2025
Copyright Holders: Copyright © The Author(s) 2024
First Published: First published in Nature Medicine 31(1):258-266
Publisher Policy: Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details

ID Code: 337991
Depositing User: Mr Alastair Arthur
Datestamp: 14 Jan 2025 12:34
Last Modified: 16 Apr 2025 13:32
Date of acceptance: 30 October 2024
Date of first online publication: 8 January 2025
Date Deposited: 31 October 2024
Data Availability Statement: No